世界のIVD抗体市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global IVD Antibodies Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3294
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、IVD抗体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（心臓マーカー、腫瘍マーカー、腎臓損傷マーカー）、用途別市場規模（病院、専門クリニック、診断センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・IVD抗体の市場動向
・企業の競争状況、市場シェア
・IVD抗体の種類別市場規模（心臓マーカー、腫瘍マーカー、腎臓損傷マーカー）
・IVD抗体の用途別市場規模（病院、専門クリニック、診断センター、その他）
・IVD抗体の北米市場規模2016-2027（アメリカ、カナダ）
・IVD抗体のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・IVD抗体のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・IVD抗体の中南米市場規模2016-2027（メキシコ、ブラジル）
・IVD抗体の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Abcam、Thermo Fisher Scientific、Rockland Immunochemicals、GenScript、Bio-Rad Laboratories、SDIX、MEDICAL & BIOLOGICAL LABORATORIES、HyTest、Abbott）
・結論

In vitro diagnostics tests are used in laboratories, healthcare settings or directly by consumers at home for the detection of various diseases, infections and other medical conditions. Various companies in the IVD antibodies market are focusing on mergers and acquisitions with regional players. For example, in Sep. 2018, Summa Equity AB acquired Turku-based HyTest Ltd. whose regional presence in the U.S. and Asia is good. Continuously evolving nature of IVD antibodies market further expected to get maximum traction. Superior capability of the IVD antibodies to detect complex diseases such as cancer and use of IVD antibodies in therapeutic monitoring, evaluating blood safety before transfusion further makes it preferred choice of diagnosis test.

Market Analysis and Insights: Global IVD Antibodies Market
The global IVD Antibodies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global IVD Antibodies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global IVD Antibodies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global IVD Antibodies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global IVD Antibodies market.

Global IVD Antibodies Scope and Market Size
IVD Antibodies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global IVD Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Cardiac Markers
Tumor Markers
Kidney Injury Markers

Segment by Application
Hospital
Specialty Clinic
Diagnostic Center
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abcam
Thermo Fisher Scientific
Rockland Immunochemicals
GenScript
Bio-Rad Laboratories
SDIX
MEDICAL & BIOLOGICAL LABORATORIES
HyTest
Abbott

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IVD Antibodies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cardiac Markers
1.2.3 Tumor Markers
1.2.4 Kidney Injury Markers
1.3 Market by Application
1.3.1 Global IVD Antibodies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Diagnostic Center
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global IVD Antibodies Market Perspective (2016-2027)
2.2 IVD Antibodies Growth Trends by Regions
2.2.1 IVD Antibodies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 IVD Antibodies Historic Market Share by Regions (2016-2021)
2.2.3 IVD Antibodies Forecasted Market Size by Regions (2022-2027)
2.3 IVD Antibodies Industry Dynamic
2.3.1 IVD Antibodies Market Trends
2.3.2 IVD Antibodies Market Drivers
2.3.3 IVD Antibodies Market Challenges
2.3.4 IVD Antibodies Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top IVD Antibodies Players by Revenue
3.1.1 Global Top IVD Antibodies Players by Revenue (2016-2021)
3.1.2 Global IVD Antibodies Revenue Market Share by Players (2016-2021)
3.2 Global IVD Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by IVD Antibodies Revenue
3.4 Global IVD Antibodies Market Concentration Ratio
3.4.1 Global IVD Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IVD Antibodies Revenue in 2020
3.5 IVD Antibodies Key Players Head office and Area Served
3.6 Key Players IVD Antibodies Product Solution and Service
3.7 Date of Enter into IVD Antibodies Market
3.8 Mergers & Acquisitions, Expansion Plans

4 IVD Antibodies Breakdown Data by Type
4.1 Global IVD Antibodies Historic Market Size by Type (2016-2021)
4.2 Global IVD Antibodies Forecasted Market Size by Type (2022-2027)

5 IVD Antibodies Breakdown Data by Application
5.1 Global IVD Antibodies Historic Market Size by Application (2016-2021)
5.2 Global IVD Antibodies Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America IVD Antibodies Market Size (2016-2027)
6.2 North America IVD Antibodies Market Size by Type
6.2.1 North America IVD Antibodies Market Size by Type (2016-2021)
6.2.2 North America IVD Antibodies Market Size by Type (2022-2027)
6.2.3 North America IVD Antibodies Market Size by Type (2016-2027)
6.3 North America IVD Antibodies Market Size by Application
6.3.1 North America IVD Antibodies Market Size by Application (2016-2021)
6.3.2 North America IVD Antibodies Market Size by Application (2022-2027)
6.3.3 North America IVD Antibodies Market Size by Application (2016-2027)
6.4 North America IVD Antibodies Market Size by Country
6.4.1 North America IVD Antibodies Market Size by Country (2016-2021)
6.4.2 North America IVD Antibodies Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe IVD Antibodies Market Size (2016-2027)
7.2 Europe IVD Antibodies Market Size by Type
7.2.1 Europe IVD Antibodies Market Size by Type (2016-2021)
7.2.2 Europe IVD Antibodies Market Size by Type (2022-2027)
7.2.3 Europe IVD Antibodies Market Size by Type (2016-2027)
7.3 Europe IVD Antibodies Market Size by Application
7.3.1 Europe IVD Antibodies Market Size by Application (2016-2021)
7.3.2 Europe IVD Antibodies Market Size by Application (2022-2027)
7.3.3 Europe IVD Antibodies Market Size by Application (2016-2027)
7.4 Europe IVD Antibodies Market Size by Country
7.4.1 Europe IVD Antibodies Market Size by Country (2016-2021)
7.4.2 Europe IVD Antibodies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific IVD Antibodies Market Size (2016-2027)
8.2 Asia-Pacific IVD Antibodies Market Size by Type
8.2.1 Asia-Pacific IVD Antibodies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific IVD Antibodies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific IVD Antibodies Market Size by Type (2016-2027)
8.3 Asia-Pacific IVD Antibodies Market Size by Application
8.3.1 Asia-Pacific IVD Antibodies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific IVD Antibodies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific IVD Antibodies Market Size by Application (2016-2027)
8.4 Asia-Pacific IVD Antibodies Market Size by Region
8.4.1 Asia-Pacific IVD Antibodies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific IVD Antibodies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America IVD Antibodies Market Size (2016-2027)
9.2 Latin America IVD Antibodies Market Size by Type
9.2.1 Latin America IVD Antibodies Market Size by Type (2016-2021)
9.2.2 Latin America IVD Antibodies Market Size by Type (2022-2027)
9.2.3 Latin America IVD Antibodies Market Size by Type (2016-2027)
9.3 Latin America IVD Antibodies Market Size by Application
9.3.1 Latin America IVD Antibodies Market Size by Application (2016-2021)
9.3.2 Latin America IVD Antibodies Market Size by Application (2022-2027)
9.3.3 Latin America IVD Antibodies Market Size by Application (2016-2027)
9.4 Latin America IVD Antibodies Market Size by Country
9.4.1 Latin America IVD Antibodies Market Size by Country (2016-2021)
9.4.2 Latin America IVD Antibodies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa IVD Antibodies Market Size (2016-2027)
10.2 Middle East & Africa IVD Antibodies Market Size by Type
10.2.1 Middle East & Africa IVD Antibodies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa IVD Antibodies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa IVD Antibodies Market Size by Type (2016-2027)
10.3 Middle East & Africa IVD Antibodies Market Size by Application
10.3.1 Middle East & Africa IVD Antibodies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa IVD Antibodies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa IVD Antibodies Market Size by Application (2016-2027)
10.4 Middle East & Africa IVD Antibodies Market Size by Country
10.4.1 Middle East & Africa IVD Antibodies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa IVD Antibodies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Details
11.1.2 Abcam Business Overview
11.1.3 Abcam IVD Antibodies Introduction
11.1.4 Abcam Revenue in IVD Antibodies Business (2016-2021)
11.1.5 Abcam Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific IVD Antibodies Introduction
11.2.4 Thermo Fisher Scientific Revenue in IVD Antibodies Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Rockland Immunochemicals
11.3.1 Rockland Immunochemicals Company Details
11.3.2 Rockland Immunochemicals Business Overview
11.3.3 Rockland Immunochemicals IVD Antibodies Introduction
11.3.4 Rockland Immunochemicals Revenue in IVD Antibodies Business (2016-2021)
11.3.5 Rockland Immunochemicals Recent Development
11.4 GenScript
11.4.1 GenScript Company Details
11.4.2 GenScript Business Overview
11.4.3 GenScript IVD Antibodies Introduction
11.4.4 GenScript Revenue in IVD Antibodies Business (2016-2021)
11.4.5 GenScript Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Details
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories IVD Antibodies Introduction
11.5.4 Bio-Rad Laboratories Revenue in IVD Antibodies Business (2016-2021)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 SDIX
11.6.1 SDIX Company Details
11.6.2 SDIX Business Overview
11.6.3 SDIX IVD Antibodies Introduction
11.6.4 SDIX Revenue in IVD Antibodies Business (2016-2021)
11.6.5 SDIX Recent Development
11.7 MEDICAL & BIOLOGICAL LABORATORIES
11.7.1 MEDICAL & BIOLOGICAL LABORATORIES Company Details
11.7.2 MEDICAL & BIOLOGICAL LABORATORIES Business Overview
11.7.3 MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Introduction
11.7.4 MEDICAL & BIOLOGICAL LABORATORIES Revenue in IVD Antibodies Business (2016-2021)
11.7.5 MEDICAL & BIOLOGICAL LABORATORIES Recent Development
11.8 HyTest
11.8.1 HyTest Company Details
11.8.2 HyTest Business Overview
11.8.3 HyTest IVD Antibodies Introduction
11.8.4 HyTest Revenue in IVD Antibodies Business (2016-2021)
11.8.5 HyTest Recent Development
11.9 Abbott
11.9.1 Abbott Company Details
11.9.2 Abbott Business Overview
11.9.3 Abbott IVD Antibodies Introduction
11.9.4 Abbott Revenue in IVD Antibodies Business (2016-2021)
11.9.5 Abbott Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global IVD Antibodies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cardiac Markers
Table 3. Key Players of Tumor Markers
Table 4. Key Players of Kidney Injury Markers
Table 5. Global IVD Antibodies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global IVD Antibodies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global IVD Antibodies Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global IVD Antibodies Market Share by Regions (2016-2021)
Table 9. Global IVD Antibodies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global IVD Antibodies Market Share by Regions (2022-2027)
Table 11. IVD Antibodies Market Trends
Table 12. IVD Antibodies Market Drivers
Table 13. IVD Antibodies Market Challenges
Table 14. IVD Antibodies Market Restraints
Table 15. Global IVD Antibodies Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global IVD Antibodies Market Share by Players (2016-2021)
Table 17. Global Top IVD Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IVD Antibodies as of 2020)
Table 18. Ranking of Global Top IVD Antibodies Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by IVD Antibodies Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players IVD Antibodies Product Solution and Service
Table 22. Date of Enter into IVD Antibodies Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global IVD Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 25. Global IVD Antibodies Revenue Market Share by Type (2016-2021)
Table 26. Global IVD Antibodies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global IVD Antibodies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global IVD Antibodies Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global IVD Antibodies Revenue Market Share by Application (2016-2021)
Table 30. Global IVD Antibodies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global IVD Antibodies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America IVD Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 33. North America IVD Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America IVD Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 35. North America IVD Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America IVD Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America IVD Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe IVD Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe IVD Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe IVD Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe IVD Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe IVD Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe IVD Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific IVD Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific IVD Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific IVD Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific IVD Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific IVD Antibodies Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific IVD Antibodies Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America IVD Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America IVD Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America IVD Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America IVD Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America IVD Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America IVD Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa IVD Antibodies Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa IVD Antibodies Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa IVD Antibodies Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa IVD Antibodies Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa IVD Antibodies Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa IVD Antibodies Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abcam Company Details
Table 63. Abcam Business Overview
Table 64. Abcam IVD Antibodies Product
Table 65. Abcam Revenue in IVD Antibodies Business (2016-2021) & (US$ Million)
Table 66. Abcam Recent Development
Table 67. Thermo Fisher Scientific Company Details
Table 68. Thermo Fisher Scientific Business Overview
Table 69. Thermo Fisher Scientific IVD Antibodies Product
Table 70. Thermo Fisher Scientific Revenue in IVD Antibodies Business (2016-2021) & (US$ Million)
Table 71. Thermo Fisher Scientific Recent Development
Table 72. Rockland Immunochemicals Company Details
Table 73. Rockland Immunochemicals Business Overview
Table 74. Rockland Immunochemicals IVD Antibodies Product
Table 75. Rockland Immunochemicals Revenue in IVD Antibodies Business (2016-2021) & (US$ Million)
Table 76. Rockland Immunochemicals Recent Development
Table 77. GenScript Company Details
Table 78. GenScript Business Overview
Table 79. GenScript IVD Antibodies Product
Table 80. GenScript Revenue in IVD Antibodies Business (2016-2021) & (US$ Million)
Table 81. GenScript Recent Development
Table 82. Bio-Rad Laboratories Company Details
Table 83. Bio-Rad Laboratories Business Overview
Table 84. Bio-Rad Laboratories IVD Antibodies Product
Table 85. Bio-Rad Laboratories Revenue in IVD Antibodies Business (2016-2021) & (US$ Million)
Table 86. Bio-Rad Laboratories Recent Development
Table 87. SDIX Company Details
Table 88. SDIX Business Overview
Table 89. SDIX IVD Antibodies Product
Table 90. SDIX Revenue in IVD Antibodies Business (2016-2021) & (US$ Million)
Table 91. SDIX Recent Development
Table 92. MEDICAL & BIOLOGICAL LABORATORIES Company Details
Table 93. MEDICAL & BIOLOGICAL LABORATORIES Business Overview
Table 94. MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Product
Table 95. MEDICAL & BIOLOGICAL LABORATORIES Revenue in IVD Antibodies Business (2016-2021) & (US$ Million)
Table 96. MEDICAL & BIOLOGICAL LABORATORIES Recent Development
Table 97. HyTest Company Details
Table 98. HyTest Business Overview
Table 99. HyTest Revenue in IVD Antibodies Business (2016-2021) & (US$ Million)
Table 100. HyTest Recent Development
Table 101. Abbott Company Details
Table 102. Abbott Business Overview
Table 103. Abbott IVD Antibodies Product
Table 104. Abbott Revenue in IVD Antibodies Business (2016-2021) & (US$ Million)
Table 105. Abbott Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global IVD Antibodies Market Share by Type: 2020 VS 2027
Figure 2. Cardiac Markers Features
Figure 3. Tumor Markers Features
Figure 4. Kidney Injury Markers Features
Figure 5. Global IVD Antibodies Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Specialty Clinic Case Studies
Figure 8. Diagnostic Center Case Studies
Figure 9. Others Case Studies
Figure 10. IVD Antibodies Report Years Considered
Figure 11. Global IVD Antibodies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global IVD Antibodies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global IVD Antibodies Market Share by Regions: 2020 VS 2027
Figure 14. Global IVD Antibodies Market Share by Regions (2022-2027)
Figure 15. Global IVD Antibodies Market Share by Players in 2020
Figure 16. Global Top IVD Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IVD Antibodies as of 2020
Figure 17. The Top 10 and 5 Players Market Share by IVD Antibodies Revenue in 2020
Figure 18. Global IVD Antibodies Revenue Market Share by Type (2016-2021)
Figure 19. Global IVD Antibodies Revenue Market Share by Type (2022-2027)
Figure 20. North America IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America IVD Antibodies Market Share by Type (2016-2027)
Figure 22. North America IVD Antibodies Market Share by Application (2016-2027)
Figure 23. North America IVD Antibodies Market Share by Country (2016-2027)
Figure 24. United States IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe IVD Antibodies Market Share by Type (2016-2027)
Figure 28. Europe IVD Antibodies Market Share by Application (2016-2027)
Figure 29. Europe IVD Antibodies Market Share by Country (2016-2027)
Figure 30. Germany IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific IVD Antibodies Market Share by Type (2016-2027)
Figure 38. Asia-Pacific IVD Antibodies Market Share by Application (2016-2027)
Figure 39. Asia-Pacific IVD Antibodies Market Share by Region (2016-2027)
Figure 40. China IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America IVD Antibodies Market Share by Type (2016-2027)
Figure 48. Latin America IVD Antibodies Market Share by Application (2016-2027)
Figure 49. Latin America IVD Antibodies Market Share by Country (2016-2027)
Figure 50. Mexico IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa IVD Antibodies Market Share by Type (2016-2027)
Figure 54. Middle East & Africa IVD Antibodies Market Share by Application (2016-2027)
Figure 55. Middle East & Africa IVD Antibodies Market Share by Country (2016-2027)
Figure 56. Turkey IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Abcam Revenue Growth Rate in IVD Antibodies Business (2016-2021)
Figure 60. Thermo Fisher Scientific Revenue Growth Rate in IVD Antibodies Business (2016-2021)
Figure 61. Rockland Immunochemicals Revenue Growth Rate in IVD Antibodies Business (2016-2021)
Figure 62. GenScript Revenue Growth Rate in IVD Antibodies Business (2016-2021)
Figure 63. Bio-Rad Laboratories Revenue Growth Rate in IVD Antibodies Business (2016-2021)
Figure 64. SDIX Revenue Growth Rate in IVD Antibodies Business (2016-2021)
Figure 65. MEDICAL & BIOLOGICAL LABORATORIES Revenue Growth Rate in IVD Antibodies Business (2016-2021)
Figure 66. HyTest Revenue Growth Rate in IVD Antibodies Business (2016-2021)
Figure 67. Abbott Revenue Growth Rate in IVD Antibodies Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界のHER2抗体市場規模・現状・予測（2021年-2027年）

Global HER2 Antibodies Market Size, Status and Forecast 2021-2027
QYR2104Z2800 2021年4月 93Pages
QYResearch社発行の本調査資料では、HER2抗体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（トラスツズマブ、ラパチニブ、アド-トラスツズマブエムタンシン、ペルツズマブ、エベロリムス）、用途別市場規模（病院薬局、小売薬局、Eコマース）...

世界のIGYポリクローナル抗体市場規模・現状・予測（2021年-2027年）

Global IGY Polyclonal Antibodies Market Size, Status and Forecast 2021-2027
QYR2104Z3024 2021年4月 95Pages
QYResearch社発行の本調査資料では、IGYポリクローナル抗体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（一次抗体、二次抗体）、用途別市場規模（学術研究、商業）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国...

世界の乳がん用モノクローナル抗体市場規模・現状・予測（2021年-2027年）

Global Breast Cancer Monoclonal Antibodies Market Size, Status and Forecast 2021-2027
QYR2104Z0992 2021年4月 126Pages
QYResearch社発行の本調査資料では、乳がん用モノクローナル抗体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ネイキッドMAb、コンジュゲートMAb）、用途別市場規模（病院、小売薬局、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界のEXTL1抗体市場規模・現状・予測（2021年-2027年）

Global EXTL1 Antibody Market Size, Status and Forecast 2021-2027
QYR2104Z2285 2021年4月 99Pages
QYResearch社発行の本調査資料では、EXTL1抗体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（95％以上、99％以上、その他）、用途別市場規模（バイオ製薬会社、病院、生物科学研究機関、その他）、主要地域別市場規模（北米、アメリカ、ヨ...

世界のCD3E市場規模・現状・予測（2021年-2027年）

Global CD3E Market Size, Status and Forecast 2021-2027
QYR2104Z1167 2021年4月 93Pages
QYResearch社発行の本調査資料では、CD3Eのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（90％以上、95％以上、99％以上、その他）、用途別市場規模（バイオ医薬品会社、バイオサイエンス研究機関、その他）、主要地域別市場規模（北米、ア...

世界のFAM20B遺伝子（XYLK抗体）市場規模・現状・予測（2021年-2027年）

Global FAM20B Gene(XYLK Antibody) Market Size, Status and Forecast 2021-2027
QYR2104Z2313 2021年4月 92Pages
QYResearch社発行の本調査資料では、FAM20B遺伝子（XYLK抗体）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（90％以上、95％以上、99％以上、その他）、用途別市場規模（バイオ製薬会社、病院、生物科学研究機関、その他）、主要地...

世界のCASP3市場規模・現状・予測（2021年-2027年）

Global CASP3 Market Size, Status and Forecast 2021-2027
QYR2104Z1148 2021年4月 96Pages
QYResearch社発行の本調査資料では、CASP3のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（90％以上、95％以上、99％以上、その他）、用途別市場規模（バイオ医薬品会社、バイオサイエンス研究機関、その他）、主要地域別市場規模（北米、...

世界の補体欠損検査市場規模・現状・予測（2021年-2027年）

Global Complement Deficiency Tests Market Size, Status and Forecast 2021-2027
QYR2104Z1505 2021年4月 91Pages
QYResearch社発行の本調査資料では、補体欠損検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血清学的・免疫学的アッセイ、分子診断検査、免疫組織化学技術、その他）、用途別市場規模（病院、診断研究所、研究所）、主要地域別市場規模（北米、...

世界のEPAS1抗体市場規模・現状・予測（2021年-2027年）

Global EPAS1 Antibody Market Size, Status and Forecast 2021-2027
QYR2104Z2224 2021年4月 99Pages
QYResearch社発行の本調査資料では、EPAS1抗体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（95％以上、99％以上、その他）、用途別市場規模（バイオ製薬会社、病院、生物科学研究機関、その他）、主要地域別市場規模（北米、アメリカ、ヨ...

世界の抗核抗体（ANA）検査市場規模・現状・予測（2021年-2027年）

Global Antinuclear Antibody (ANA) Test Market Size, Status and Forecast 2021-2027
QYR2104Z0404 2021年4月 96Pages
QYResearch社発行の本調査資料では、抗核抗体（ANA）検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（試薬・アッセイキット、システム、ソフトウェア・サービス）、用途別市場規模（病院、臨床検査室、診療所検査室、その他）、主要地域別市場...

世界のHER2抗体市場規模・現状・予測（2021年-2027年） The demand of HER2 Antibodies is increasing, and primarily gaining from growing awareness regarding the prevalence of HER2 positive breast cancer. Market Analysis and Insights: Global HER2 Antibodies Market The global HER2 Antibodies market size is projected to reach US$ 11440 million by 2026, from …
世界のIGYポリクローナル抗体市場規模・現状・予測（2021年-2027年） Immunoglobulin Y (abbreviated as IgY) is a type of immunoglobulin which is the major antibody in bird, reptile, and lungfish blood. It is also found in high concentrations in chicken egg yolk. As with the other immunoglobulins, IgY is a class of proteins which are formed by the immune system in reac…
世界の乳がん用モノクローナル抗体市場規模・現状・予測（2021年-2027年） Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protei…
世界の基準マーカー市場 2021：企業別、地域別、種類・用途別 The Fiducial Markers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
世界の電子ケーブルマーカー市場 2021：企業別、地域別、種類・用途別 The Electronic Cable Markers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…